Evidence map›Paper›PMID 36105785›Full record

ArticleInternational journal of clinical practice2022

Investigation of Effect of the Colistin Loading Dosage on the clinical, Microbiological, and Laboratory Results in

Ayşegül Seremet Keski N, Derya Seyman, Kübra Demir Önder, Filiz Kizilateş, Olgun Keski N

Open access · goldAbstract read
In one paragraph

Article in International journal of clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ayşegül Seremet Keski NUniversity of Health Sciences Antalya Training and Research Hospital, Infectious Disease and Clinical Microbiology, Antalya, Turkey.ORCID https://orcid.org/0000-0002-9224-4699
Derya SeymanUniversity of Health Sciences Antalya Training and Research Hospital, Infectious Disease and Clinical Microbiology, Antalya, Turkey.ORCID https://orcid.org/0000-0002-7451-8537
Kübra Demir ÖnderUniversity of Health Sciences Antalya Training and Research Hospital, Infectious Disease and Clinical Microbiology, Antalya, Turkey.ORCID https://orcid.org/0000-0002-4164-5118
Filiz KizilateşUniversity of Health Sciences Antalya Training and Research Hospital, Infectious Disease and Clinical Microbiology, Antalya, Turkey.
Olgun Keski NUniversity of Health Sciences Antalya Training and Research Hospital, Department of Pulmomology., Antalya, Turkey.ORCID https://orcid.org/0000-0002-0995-7680
Antalya Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials and Methods: Adult patients administered colistin with and without LD for MDR Results: A total of 101 patients were included (colistin with LD, Conclusion: Colistin with LD was associated with a higher risk of nephrotoxicity and was not related to clinical success, microbiological success, and prolonged survival. Randomized comparative studies are needed to confirm the efficacy of LD colistin regimen on MDR

Indexed as

Acinetobacter baumanniiPneumonia, Ventilator-AssociatedRenal InsufficiencyAdultAnti-Bacterial AgentsColistinDrug Resistance, Multiple, BacterialHumansRetrospective StudiesAnti-Bacterial AgentsColistin

Identifiers

PMID36105785
PMCPMC9441370
OpenAlexW4293653710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.